Tumor analysis for human epidermal growth factor receptor 2 (HER2) was performed by HercepTest ventana indicating a Strong complete, basolateral membranous reactivity in > 80% of the tumor cells in favor of 3+ immunohistochemistry (IHC) staining (Figure 1). The gene discussed is ERBB2; the disease is neoplasm.